NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pragma Bio

Pragma Bio

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.pragmabio.com/

Last Round

Series A

Mar 23, 2023

Total Funding Raised

$14.5M

Company Overview

Pragma Bio is a biotechnology company that uses an AI-powered platform and synthetic biology to discover and develop small molecule medicines derived from the human gut microbiome for immunological disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverymicrobiome therapeuticssynthetic biologymetagenomicsAI drug discoverygut-immune axisin silico drug discoverybiomanufacturingai biotechmicrobiome miningbiosynthetic gene clustersBGCsmall molecule discoverybioinformaticsprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pragma Bio Comparables

Compare Pragma Bio with similar companies based on industry and business-model similarity.

Pragma Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wild Biotech
82%
Hexagon Bio
82%
Persephone Biosciences
82%

Pragma Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 23, 2023
SeedDec 15, 2020

Key People

Founding team and executive leadership

Mohamed Donia

Scientific Co-Founder And Chief Scientific Officer

Founding Team

Peter McCaffrey

CTO, Co-Founder

Founding Team

Kareem Barghouti

Co-Founder, CEO

Founding Team

Pragma Bio Investors

Notable investors and investment history

Pragma Bio investors
InvestorRounds
CJ InvestmentSeed
Viking Global InvestorsSeries A, Seed
The Venture CollectiveSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2023

    $10M round led by The Venture Collective.

Pragma Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pragma Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pragma Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range17
Year Founded2018
Last FundingMar 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.